Changes of hCNT1 mRNA expression showed a trend toward an increase after silencing miR-106a in both CRC and PDAC cell lines, whereas this trend was only observed in PDAC cell lines following miR-17 silencing (Fig. 4 C).
← all excerpts
OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1.
2
—
—
The sentences
Under conditions of miR-106a and miR-17 knockdown using both approaches, nucleoside uptake rates in spheroids showed an increasing trend, although this difference fell short of statistical significance (Fig. 6 B).